Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
scPharmaceuticals Appoints Frederick Hudson to Board of DirectorsBURLINGTON, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, announced at its 2018 Annual Meeting of Stockholders that Frederick M. Hudson was elected to the Company’s Board of Directors, replacing Abhay Gandhi, whose term on the Board ended. Mr. Hudson will act as an in […]
scPharmaceuticals Receives Complete Response Letter from the FDA for FUROSCIX®BURLINGTON, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced the Company received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the 505(b)(2) application for FUROSCIX®, a treatment candidate for edema, or flui […]
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®BURLINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that, on May 30, 2018, the Company received a letter from the U.S. Food and Drug Administration (FDA) as part of the FDA’s ongoing review of the Company’s New Drug Application (NDA) for FUROSCIX® […]
scPharmaceuticals Inc. to Present at the Jefferies 2018 Global Healthcare ConferenceBURLINGTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer, will present at the Jefferies 2018 Global Healthcare Conference at 2:00 p.m. ET on Wednesday, Ju […]
scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business UpdateCompany’s lead investigational product, FUROSCIX®, has a PDUFA date of June 23, 2018 Company has initiated staged commercialization activities for FUROSCIX BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced financial results for the first qua […]
scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial ResultsAnnounced $147.7 Million of equity capital raising in 2017;  Completed an Initial Public Offering;  Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize delivery of infused therapies, advance patient care and reduce healthcare costs, today announced financial results for the fourth quarter and full year […]
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care ConferenceBURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer of scPharmaceuticals, will present at the Cowen 38th Annual Health Care Conference at 10:40 a.m. ET on Wednesd […]
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare ConferenceBURLINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer of scPharmaceuticals, will present at the 7th Annual Leerink Partners Global Healthcare Conference at 11:30 a.m […]